BENEFIT OF INFLIXIMAB RE-INTRODUCTION AFTER SUCCESSIVE FAILURE OF INFLIXIMAB AND ADALIMUMAB IN INFLAMMATORY BOWEL DISEASES
Charlotte Gagniere 1
Laurent Beaugerie 1
Benjamin Pariente 2
Philippe Seksik 1
Aurelien Amiot 3
Vered Abitbol 4
Matthieu Allez 2
Jacques Cosnes 1
Harry Sokol 1
1 Saint Antoine Hospital
2 Saint Louis Hospital
3 Mondor Hospital
4 Cochin Hospital
Session
IBD I
Conference
UEG Week 2013
Citation
United European Gastroenterology Journal; 2013: 1 (Supplement 1) A217
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing